Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days, according to sources. The size, pricing and buyers are yet to be determined.
Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days, according to sources. The size, pricing and buyers are yet to be determined.